38
Participants
Start Date
December 7, 2016
Primary Completion Date
January 5, 2018
Study Completion Date
January 5, 2018
Nivolumab
Specified dose on specified days
Duke University Medical Center, Durham
Pulmonary And Critical Care Of Atlanta, Atlanta
University Of Florida, Gainesville
University Of Kentucky, Lexington
The Ohio State University, Columbus
Osf Saint Francis Medical Center, Peoria
Washington University School Of Medicine, St Louis
Denver Health Medical Center, Denver
Univ. Of Colorado Health, Colorado Springs
Uc Davis Medical Center, Sacramento
Harborview Medical Center, Seattle
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center (BIDMC), Boston
Baystate Medical Center, Springfield
University of Michigan, Division of Acute Care Surgery, Ann Arbor
UPMC, Pittsburgh
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY